Skip to main content

Advertisement

ADVERTISEMENT

Videos

James Gelfand, JD
Videos
10/14/2022
James Gelfand, JD, The ERISA Industry Committee, discusses achieving optimal, value-driven patient care through pharmacy benefit managers, and changes in plan transparency for payers and patients at the 2022 Oncology Clinical Pathways...
James Gelfand, JD, The ERISA Industry Committee, discusses achieving optimal, value-driven patient care through pharmacy benefit managers, and changes in plan transparency for payers and patients at the 2022 Oncology Clinical Pathways...
James Gelfand, JD, The ERISA...
10/14/2022
Journal of Clinical Pathways
Atish Choudhury, MD, PhD, Dana-Farber Cancer Institute
Videos
01/12/2022
Atish Choudhury, MD, PhD, and Alicia Morgans, MD, MPH, discuss treatment modalities that have demonstrated survival benefit in metastatic castration-resistant prostate cancer for genetically unselected patients.
Atish Choudhury, MD, PhD, and Alicia Morgans, MD, MPH, discuss treatment modalities that have demonstrated survival benefit in metastatic castration-resistant prostate cancer for genetically unselected patients.
Atish Choudhury, MD, PhD, and...
01/12/2022
Journal of Clinical Pathways

Advertisement

Bryan Loy, MD, Humana
Oncology Innovations
12/01/2021

Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Gordon Kuntz; Bryan Loy, MD,...
12/01/2021
Journal of Clinical Pathways
Tushar Pandey
Oncology Innovations
11/17/2021
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss current approaches to personalized medicine, how precision medicine has evolved in recent years, challenges that remain, and considerations for the future.
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss current approaches to personalized medicine, how precision medicine has evolved in recent years, challenges that remain, and considerations for the future.
Gordon Kuntz; Bryan Loy, MD,...
11/17/2021
Journal of Clinical Pathways
Sibel Blau
Videos
11/17/2021
Frederick Schnell, MD, and Sibel Blau, MD, discuss the rapid evolution of cancer care delivery and value based care in the Quality Cancer Care Alliance Network.
Frederick Schnell, MD, and Sibel Blau, MD, discuss the rapid evolution of cancer care delivery and value based care in the Quality Cancer Care Alliance Network.
Frederick Schnell, MD, and Sibel...
11/17/2021
Journal of Clinical Pathways

Advertisement

Theresa Schmidt
Videos
08/25/2021
Theresa Schmidt, MA, and Kimberly Westrich, MA, discuss the role of patient-reported measures and value-based payment models in patient-centered cancer care.
Theresa Schmidt, MA, and Kimberly Westrich, MA, discuss the role of patient-reported measures and value-based payment models in patient-centered cancer care.
Theresa Schmidt, MA, and...
08/25/2021
Journal of Clinical Pathways
Fred Schnell
Videos
08/06/2021
Frederick Schnell, MD, FACP; Bo Gamble; and John Cox, DO, MBA, FACP, FASCO, discuss the ASCO-COA Oncology Medical Home standards, current quality initiatives for cancer care delivery, and where quality initiatives are advancing in the future.
Frederick Schnell, MD, FACP; Bo Gamble; and John Cox, DO, MBA, FACP, FASCO, discuss the ASCO-COA Oncology Medical Home standards, current quality initiatives for cancer care delivery, and where quality initiatives are advancing in the future.
Frederick Schnell, MD, FACP; Bo...
08/06/2021
Journal of Clinical Pathways
Videos
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network

Advertisement

Videos
06/23/2021
Winston Wong, PharmD, and Stephen Schleicher, MD, MBA, discuss the clinical pathways program at Tennessee Oncology and new value-based care considerations in the era of precision medicine.
Winston Wong, PharmD, and Stephen Schleicher, MD, MBA, discuss the clinical pathways program at Tennessee Oncology and new value-based care considerations in the era of precision medicine.
Winston Wong, PharmD, and...
06/23/2021
Journal of Clinical Pathways
Videos
06/23/2021
David O'Malley, MD, discusses results from a subgroup analysis of the ARIEL4 trial, comparing rucaparib vs chemotherapy among platinum-sensitive patients with ovarian cancer.
David O'Malley, MD, discusses results from a subgroup analysis of the ARIEL4 trial, comparing rucaparib vs chemotherapy among platinum-sensitive patients with ovarian cancer.
David O'Malley, MD, discusses...
06/23/2021
Journal of Clinical Pathways

Advertisement